Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study.
Jun-Jie MaoXiao ZangWan-Lu YuePei-Yao ZhaiQiong ZhangChun-Hu LiXun ZhuangXiaoli LiuGang QinPublished in: BMJ global health (2023)
Vaccae represents a robust and cost-effective choice for TB epidemic control in China. This study may facilitate the practice of evidence-based strategy plans for TB vaccination and reimbursement decision making.